Shattuck Labs, Inc. (STTK)
Develops antibody drugs to treat inflammatory and immune diseases.
$6.76-0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+823.5%
The outlook
STTK is trading at $6.76 with strong analyst support, consensus leaning heavily toward Buy across eight covering firms. The stock sits well above its major moving averages and nearly three-quarters of the way up its 52-week range, reflecting solid upward momentum. Analysts' average price target sits roughly double the current price, though this represents their collective view, not a guarantee.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 8 analysts
Price trendAbove its 50- & 200-day averages
52-week range79% of the way from its 52-week low to high
Price targetAvg target +113% vs current price
Analyst price target
~12-month · 8 analysts$14.38average target+112.6% vs now
Now $6.76
Low $10.00High $18.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$645.6M
52-wk high
$8.33
52-wk low
$0.71
50-day avg
$6.00
200-day avg
$4.71
Trailing P/E
—